Results
|
|
141.
|
|
|
|
142.
|
|
|
|
143.
|
|
|
|
144.
|
|
|
|
145.
|
|
|
|
146.
|
|
|
|
147.
|
|
|
|
148.
|
|
|
|
149.
|
|
|
|
150.
|
|
|
|
151.
|
|
|
|
152.
|
Commentary on "AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer." Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, Chen Y, Mohammad TA, Chen Y, Fedor HL, Lotan TL, Zheng Q, De Marzo AM, Isaacs JT, Isaacs WB, Nadal R, Paller CJ, Denmeade SR, Carducci MA, Eisenberger MA, Luo J, Division of Urologic Oncology, Department of Urology, University of Michigan, MI. N Engl J Med 2014; 371(11):1028-38. [electronic resource] by Producer: 20180301
In:
Urologic oncology vol. 34
Availability: No items available.
|
|
|
153.
|
|
|
|
154.
|
|
|
|
155.
|
|
|
|
156.
|
|
|
|
157.
|
|
|
|
158.
|
|
|
|
159.
|
|
|
|
160.
|
|